However, even though this quite unexplored area may seem far beyond the scope of our current study, it does suggests that differential signaling pathways as well as different purinergic receptors might be activated in CRC, leading to distinctive cellular outcomes [43]. This evidence concerns the gene P2RY1 and colorectal carcinoma.